{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-041801","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2026-09-08T21:24:25+00:00","discovered_at":"2026-09-08T21:26:00.609914+00:00","generated_at":"2026-09-08T21:26:08.781712+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Hepion Pharmaceuticals issues $500K secured convertible note to Gravitas Capital","bullets":["$500,000 secured convertible note with 8% paid-in-kind interest, maturing Sept 3, 2027.","Note convertible at $0.04/share, contingent on stockholder approval to increase authorized shares.","Warrant to buy 12.5M common shares at $0.06, exercisable until Sept 3, 2031.","Note secured by all company assets; sale is unregistered under Regulation D/4(a)(2)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-041801","json":"https://secwatch.observer/filing/0001493152-26-041801.json","markdown":"https://secwatch.observer/filing/0001493152-26-041801.md","text":"https://secwatch.observer/filing/0001493152-26-041801.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226041801/0001493152-26-041801-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226041801/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-08T21:26:08.781712+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}